Search Results - Sharmeen Uddin

  • Showing 1 - 3 results of 3
Refine Results
  1. 1
    Combined EGFR/MEK Inhibition Prevents the Emergence of Resistance in <i>EGFR</i>-Mutant Lung Cancer

    Combined EGFR/MEK Inhibition Prevents the Emergence of Resistance in <i>EGFR</i>-Mutant Lung Cancer by Erin M. Tricker, Chunxiao Xu, Sharmeen Uddin, Marzia Capelletti, Dalia Ercan, Atsuko Ogino, Christine A. Pratilas, Neal Rosen, Nathanael S. Gray, Kwok‐Kin Wong, Pasi A. Jänne

    Published 2015
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  2. 2
    A Secondary Mutation in<i>BRAF</i>Confers Resistance to RAF Inhibition in a<i>BRAF</i>V600E-Mutant Brain Tumor

    A Secondary Mutation in<i>BRAF</i>Confers Resistance to RAF Inhibition in a<i>BRAF</i>V600E-Mutant Brain Tumor by Jiawan Wang, Zhan Yao, Philip Jonsson, Amy N. Allen, Alice Can Ran Qin, Sharmeen Uddin, Ira J. Dunkel, Mary Petriccione, Katia Manova, Sofia Haque, Marc K. Rosenblum, David J. Pisapia, Neal Rosen, Barry S. Taylor, Christine A. Pratilas

    Published 2018
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  3. 3
    Activating <i>ESR1</i> Mutations Differentially Affect the Efficacy of ER Antagonists

    Activating <i>ESR1</i> Mutations Differentially Affect the Efficacy of ER Antagonists by Weiyi Toy, Hazel M. Weir, Pedram Razavi, Mandy Lawson, Anne U. Goeppert, Anne Marie Mazzola, Aaron Smith, Joanne Wilson, Christopher J. Morrow, Wai Lin Wong, Elisa de Stanchina, Kathryn E. Carlson, Teresa S. Martin, Sharmeen Uddin, Zhiqiang Li, Sean W. Fanning, John A. Katzenellenbogen, Geoffrey L. Greene, José Baselga, Sarat Chandarlapaty

    Published 2016
    Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: